Allstate’s $2B Sale of Voluntary Benefits to StanCorp
Allstate sells voluntary benefits business to StanCorp for $2B to focus on strategic growth. Gain of $600M expected from sale.
- Latest
- Trending
Allstate sells voluntary benefits business to StanCorp for $2B to focus on strategic growth. Gain of $600M expected from sale.
Syfe aims to make wealth management accessible with $27M funding for growth in Singapore, Hong Kong, and Australia.
Rachel Reeves considers private funds for Lower Thames Crossing, aiming to fulfill a £22bn gap in UK infrastructure finance.
Kiteworks secures $456M financing, marking cybersecurity funding resurgence with significant investment from Insight, Sixth Street.
CareCloud reports significant revenue growth driven by AI innovations and cost-saving strategies, marking a financial turnaround.
Mars Inc's biggest acquisition ever at $36 billion showcases their strategy in private conglomerate expansion.
Beam Therapeutics leads with CRISPR in treating genetic diseases, opening new market avenues.
Explore Morgan Stanley's top defensive stock picks for stable investments amid market volatility. Learn strategies to protect your portfolio.
Polestar 3 SUV production starts in U.S., avoiding tariffs. Delivery planned for U.S. and Europe.
Japan's Meiji Yasuda buys Allstate's business for $2B to boost global profits by 2027.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.